PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes

被引:84
|
作者
Tang, XQ [1 ]
Powelka, AM [1 ]
Soriano, NA [1 ]
Czech, MP [1 ]
Guilherme, A [1 ]
机构
[1] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA
关键词
D O I
10.1074/jbc.M501949200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glucose homeostasis is controlled by insulin in part through the stimulation of glucose transport in muscle and fat cells. This insulin signaling pathway requires phosphatidylinositol ( PI) 3-kinase- mediated 3'-polyphosphoinositide generation and activation of Akt/ protein kinase B. Previous experiments using dominant negative constructs and gene ablation in mice suggested that two phosphoinositide phosphatases, SH2 domain- containing inositol 5'- phosphatase 2 (SHIP2) and phosphatase and tensin homolog deleted on chromosome 10 (PTEN) negatively regulate this insulin signaling pathway. Here we directly tested this hypothesis by selectively inhibiting the expression of SHIP2 or PTEN in intact cultured 3T3-L1 adipocytes through the use of short interfering RNA ( siRNA). Attenuation of PTEN expression by RNAi markedly enhanced insulin-stimulated Akt and glycogen synthase kinase 3 alpha (GSK-3 alpha) phosphorylation, as well as deoxyglucose transport in 3T3-L1 adipocytes. In contrast, depletion of SHIP2 protein by about 90% surprisingly failed to modulate these insulin-regulated events under identical assay conditions. In control studies, no diminution of insulin signaling to the mitogen- activated protein kinases Erk1 and Erk2 was observed when either PTEN or SHIP2 were depleted. Taken together, these results demonstrate that endogenous PTEN functions as a suppressor of insulin signaling to glucose transport through the PI3-kinase pathway in cultured 3T3-L1 adipocytes.
引用
收藏
页码:22523 / 22529
页数:7
相关论文
共 50 条
  • [1] PTEN, but not SHIP2, suppresses insulin signaling to Akt protein kinase and glucose transport in 3T3-L1 adipocytes
    Powelka, AM
    Tang, XQ
    Soriano, NA
    Grove, CA
    Czech, MP
    Guilherme, A
    DIABETES, 2004, 53 : A14 - A14
  • [2] Bisphenol A accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway
    Masuno, H
    Iwanami, J
    Kidani, T
    Sakayama, K
    Honda, K
    TOXICOLOGICAL SCIENCES, 2005, 84 (02) : 319 - 327
  • [3] THE ROLE OF PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY IN INSULIN-STIMULATED MITOGENESIS IN 3T3-L1 ADIPOCYTES
    HAIGH, RJ
    SHEPHERD, PR
    NAVE, BT
    SIDDLE, K
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (02) : S179 - S179
  • [4] Effect of insulin on adiponectin secretion from 3t3-L1 adipocytes is phosphatidylinositol 3-kinase dependent.
    Pereira, RI
    Draznin, B
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S158 - S158
  • [5] Phosphatidylinositol 3-kinase is required for insulin-stimulated tyrosine phosphorylation of Shc in 3T3-L1 adipocytes
    Ugi, S
    Sharma, PM
    Ricketts, W
    Imamura, T
    Olefsky, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (21) : 18592 - 18597
  • [6] Insulin-induced activation of akt2 at the plasma membrane is predominantly regulated by SHIP2 in 3T3-L1 adipocytes
    Wada, T
    Sasaoka, T
    Ishihara, H
    Murakami, S
    Fukui, K
    Kobayashi, M
    DIABETES, 2003, 52 : A311 - A311
  • [7] Protein Phosphatase-2Cα as a positive regulator of insulin sensitivity through direct activation of phosphatidylinositol 3-kinase in 3T3-L1 adipocytes
    Yoshizaki, T
    Maegawa, H
    Egawa, K
    Ugi, S
    Nishio, Y
    Imamura, T
    Kobayashi, T
    Tamura, S
    Olefsky, JM
    Kashiwagi, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) : 22715 - 22726
  • [8] Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by chronic insulin treatment in 3T3-L1 adipocytes
    Sasaoka, T
    Fukui, K
    Wada, T
    Murakami, S
    Kawahara, J
    Ishihara, H
    Funaki, M
    Asano, T
    Kobayashi, M
    DIABETOLOGIA, 2005, 48 (02) : 336 - 344
  • [9] Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by the chronic insulin treatment in 3T3-L1 adipocytes
    Fukui, K
    Sasaoka, T
    Wada, T
    Murakami, S
    Ishihara, H
    Hiratani, K
    Kawahara, J
    Kobayashi, M
    DIABETES, 2003, 52 : A286 - A286
  • [10] Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by chronic insulin treatment in 3T3-L1 adipocytes
    T. Sasaoka
    K. Fukui
    T. Wada
    S. Murakami
    J. Kawahara
    H. Ishihara
    M. Funaki
    T. Asano
    M. Kobayashi
    Diabetologia, 2005, 48 : 336 - 344